| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (B Stem KO) / (B Stem WT) | Abundance Ratio (log2): (B Stem KO) / (B Stem WT) | Abundance Ratio P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT) | Abundances (Grouped): B Stem KO | Abundances (Grouped): B Stem WT | Abundances (Grouped) CV [%]: B Stem KO | Abundances (Grouped) CV [%]: B Stem WT | Abundances (Scaled): F2: 129, Sample, B Stem KO, 1 | Abundances (Scaled): F2: 130, Sample, B Stem KO, 2 | Abundances (Scaled): F2: 131, Sample, B Stem KO, 3 | Abundances (Scaled): F2: 126, Sample, B Stem WT, 1 | Abundances (Scaled): F2: 127, Sample, B Stem WT, 2 | Abundances (Scaled): F2: 128, Sample, B Stem WT, 3 | Abundances (Normalized): F2: 129, Sample, B Stem KO, 1 | Abundances (Normalized): F2: 130, Sample, B Stem KO, 2 | Abundances (Normalized): F2: 131, Sample, B Stem KO, 3 | Abundances (Normalized): F2: 126, Sample, B Stem WT, 1 | Abundances (Normalized): F2: 127, Sample, B Stem WT, 2 | Abundances (Normalized): F2: 128, Sample, B Stem WT, 3 | Abundance: F2: 129, Sample, B Stem KO, 1 | Abundance: F2: 130, Sample, B Stem KO, 2 | Abundance: F2: 131, Sample, B Stem KO, 3 | Abundance: F2: 126, Sample, B Stem WT, 1 | Abundance: F2: 127, Sample, B Stem WT, 2 | Abundance: F2: 128, Sample, B Stem WT, 3 | Abundances Count: F2: 129, Sample, B Stem KO, 1 | Abundances Count: F2: 130, Sample, B Stem KO, 2 | Abundances Count: F2: 131, Sample, B Stem KO, 3 | Abundances Count: F2: 126, Sample, B Stem WT, 1 | Abundances Count: F2: 127, Sample, B Stem WT, 2 | Abundances Count: F2: 128, Sample, B Stem WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P27601 | Guanine nucleotide-binding protein subunit alpha-13 OS=Mus musculus OX=10090 GN=Gna13 PE=1 SV=1 | 0 | 81.913 | 43 | 15 | 40 | 13 | 377 | 44 | 8.21 | 1.044 | 0.06 | 0.763507511 | 0.994992347 | 2.72 | 100.5 | 99.5 | 14 | 16.07 | 111.5 | 107.9 | 85.3 | 106.8 | 108.3 | 80.2 | 3204.5 | 3099.6 | 2450.4 | 3069.9 | 3113.4 | 2305.2 | 2804.2 | 2948.9 | 2450.4 | 2712.8 | 2909.3 | 2225.3 | 13 | 13 | 13 | 13 | 13 | 13 | cell differentiation;cellular homeostasis;regulation of biological process;response to stimulus | cytoplasm;cytosol;membrane;nucleus | catalytic activity;metal ion binding;nucleotide binding;protein binding;signal transducer activity | "Pf00025, Pf00503" | 14674 | Gna13 | 11 | Rho GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; Thrombin signalling through proteinase activated receptors (PARs); Signalling by NGF; Thromboxane signalling through TP receptor | ENSMUSG00000020611.14 | Phospholipase D signaling pathway; Regulation of actin cytoskeleton; Platelet activation; Sphingolipid signaling pathway; Long-term depression; cGMP-PKG signaling pathway; Pathways in cancer; Vascular smooth muscle contraction | G Protein Signaling Pathways; G13 Signaling Pathway; Regulation of Actin Cytoskeleton | 0 |